- Preclinical study in male C57BL6/J mice comparing vincristine alone and the full CVAD regimen, using a newly established CVAD neuropathy model.
- Mice received anakinra, a clinically approved IL-1 receptor antagonist, and the individual CVAD components were tested separately.
- Anakinra prevented vincristine-induced mechanical hypersensitivity and partly reduced CVAD-induced hypersensitivity, without worsening motor function or systemic toxicity.
- Vincristine drove grip strength loss and IL-1-dependent neuroinflammation, while cyclophosphamide and doxorubicin caused sensory hypersensitivity largely independent of IL-1R; dexamethasone did not cause sensory neuropathy.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Single case report of one patient with a novel SCN9A mutation (c.3019C>T) who underwent a common surgical procedure.
- The report describes the perioperative anesthetic course in this patient, with no comparator group.
- The patient suffered atypical complications, which the authors suggest may have been related to the SCN9A mutation.
- The authors recommend greater familiarity with sodium channelopathies, especially SCN9A-related ones, to improve perioperative management.
- Cross-sectional psychometric study of four interpretation bias tasks in 451 participants, 235 with chronic pain and 188 healthy controls, each completed twice two weeks apart.
- Compared the Ambiguous Sentences task, Encoding Recognition task, Bodily Sensations Interpretation Questionnaire, and Word Association Task on validity and reliability, alongside pain, response bias, and social desirability measures.
- Tasks appeared to share an underlying construct with good reliability, most showed modest significant associations with pain outcomes, and group differences emerged for the BSIQ and WAT.
- The authors give preliminary support for the BSIQ and WAT as reliable pain-related interpretation bias tools, while the Ambiguous Sentences task was affected by general negative response bias.
- Secondary analysis of WELBack data, including 425 people with chronic non-specific low back pain who received motor control or graded activity exercise.
- Patient and physiotherapist GPE ratings were compared for agreement, and regression models tested which pain, disability, function, quality-of-life and psychosocial factors explained them.
- Agreement was moderate (ρ=0.6, κ=0.37), and the patient model explained more variance (pseudo-R² 0.3) than the physiotherapist model (pseudo-R² 0.1).
- Both models fit better with post-intervention scores than change scores, and patient ratings were associated with psychosocial changes beyond pain, disability and function.
- This preclinical study in a rat spinal cord injury model combined patch-clamp recordings from nociceptors in vitro with behavioral testing in vivo.
- The researchers inhibited the endocannabinoid-degrading enzymes MAGL and FAAH and measured effects on CaV3 channel activity and pain-related behavior.
- MAGL and FAAH inhibition both reduced CaV3 channel activity and mechanical hypersensitivity, but only FAAH inhibition reduced spontaneous pain.
- The authors suggest that inhibiting these enzymes may be a rational approach to reducing pain hypersensitivity after spinal cord injury.
- Preclinical study using mouse trigeminal ganglia and isolated nociceptors, plus conditioned medium from the human tongue squamous carcinoma line HSC-3.
- Tested NRP1 antagonists against NGF-induced TRPV1 sensitization and periorbital allodynia, and NGF immunoneutralization and NRP1 blockade against tumor-medium effects.
- NRP1 was coexpressed with TrkA in peptidergic nociceptors and was required for NGF/TrkA pronociceptive effects; tumor-conditioned medium sensitized TRPV1 and caused allodynia, both inhibited by NGF neutralization or NRP1 blockade.
- The authors propose NRP1-targeted therapies as an alternative to NGF antibodies, which were halted for adverse effects, to mitigate oral cancer pain and possibly slow tumor growth.
- Online vignette study of 159 caregivers of children aged 12 to 18, recruited through Prolific.
- Caregivers rated how likely they were to stop their child from sports, schoolwork, chores, or social events under no-pain, acute-pain, and chronic-pain scenarios.
- Sports vignettes drew significantly more protectiveness than the other activities, and protectiveness differed between no-pain and pain scenarios but not between acute and chronic pain.
- Contrary to the authors' hypothesis, higher caregiver anxiety was associated with lower protectiveness, which the authors present as context on when protectiveness rises.
- A secondary analysis of an RCT in 521 adults with chronic low back pain compared cognitive therapy, mindfulness-based stress reduction, and behavior therapy with treatment as usual.
- Hierarchical linear modeling tested whether changes in one psychosocial mechanism in a prior session predicted changes in another mechanism in the next session.
- Lagged prior-session changes predicted next-session changes in other mechanisms, with reciprocal links between pain catastrophizing and self-efficacy and unidirectional links for mindfulness and behavioral activation.
- Individual differences in the strength of these mechanism-to-mechanism relationships predicted pre- to post-treatment outcome changes, though the abstract reports no effect sizes or p values.
- Randomized trial of 2,331 adults with high impact chronic pain, assigned to a remote Health Coach, an online painTRAINER program, or Usual Care Plus, with follow-up at 3, 6, and 12 months.
- Both cognitive behaviorally based self-management arms were compared with Usual Care Plus, which included educational materials only.
- At 6 and 12 months, 36-42% of intervention participants had sustained HICP versus 50-52% of Usual Care Plus participants, with relative risks about 0.8.
- Favorable chronic pain outcomes were more common with interventions at 6 and 12 months (relative risks 1.24-1.44), while 3-month sustained HICP differences were within chance expectation.
- Scoping review of 175 studies, including 19,457 participants, mapping sensory, motor and body perception alterations in women with chronic pelvic pain.
- Most included studies compared sensory and motor function against healthy controls, mainly using quantitative sensory testing.
- Pain-evoked tests in the pelvic region consistently showed reduced thresholds, while remote-region, motor and central nervous system findings were inconsistent.
- The authors conclude that evidence for sensory, motor and body perception alterations is emerging but inconsistent, with variable methods limiting comparison.
- A cross-sectional psychometric study of 182 Spanish-speaking Mexican American adults with chronic pain, recruited through an online panel.
- It evaluated a Mexican Spanish adaptation of the Pain Self Efficacy Questionnaire for internal consistency, structural validity, and convergent validity.
- Internal consistency was high (alpha 0.916; omega 0.915), structural fit was adequate (CFI 0.929, RMSEA 0.090), and convergent correlations were modest (r -0.15 to -0.22).
- The authors conclude the adapted PSEQ shows preliminary reliability and validity for this population, but further research is needed to confirm clinical applicability.
- This preclinical mouse study used male and female CD-1 mice to examine how spinal Hsp90 inhibition affects opioid signaling.
- The Hsp90 inhibitor 17-AAG was combined with a PKC activator or the inhibitor Go6983 and delivered into the spinal cord.
- Pan-PKC signaling contributed to enhanced opioid antinociception in tail flick and postsurgical pain models, and PKCβ was identified as the active isoform in CGRP neurons; the abstract reports no effect sizes.
- The authors conclude that Hsp90 inhibitors might improve opioid analgesia and reduce side effects, and CRISPR knockdown of PKCβ in CGRP neurons was necessary for the enhanced antinociception.
- Systematic review of 23 non-randomized studies of adults with chronic pain and trauma symptoms, drawn from over 12,000 screened records.
- Eligible studies tested psychological interventions aimed at both chronic pain and trauma-related symptoms at once.
- Five of eight pain-primary studies, three of seven trauma-primary studies, and six of eight dual-primary studies improved both pain and trauma outcomes.
- Authors concluded the most effective approach remains unclear due to heterogeneity, though psychotherapies may improve both pain and trauma; they call for standardized trial design.
- Preclinical mouse study testing chemogenetic inhibition of GRPR- and/or NPFF-expressing spinal vertical cells in itch and neuropathic pain models.
- Each population was inhibited alone and both together, and behavior was tested against chloroquine-evoked itch, mechanical sensitivity, and spontaneous pain after spared nerve injury.
- Chloroquine-evoked itch was suppressed in each inhibition condition, while baseline mechanical sensitivity, mechanical hypersensitivity, and spontaneous pain were unchanged; the abstract gives no effect sizes.
- The authors conclude both populations contribute to chloroquine-evoked itch but do not support a role in neuropathic mechanical hypersensitivity.
- Observational study of 92 thalamic stroke patients (26 with CPSP) and 30 healthy controls, using DSI and resting-state fMRI to map brain networks.
- Structural and functional networks were built and compared between CPSP and non-CPSP patients using graph theory measures.
- CPSP patients had higher clustering and efficiency, lower path length, and lower structure-function coupling (PBonferroni<0.05); pain severity correlated with several network measures (PAdjusted<0.05).
- The authors propose structural reorganization and structure-function decoupling as a possible mechanism for CPSP, with potential for network-based biomarkers and neuromodulation targets.
- Preclinical mouse study comparing global and myeloid-lineage-specific α7 nicotinic receptor (Chrna7) knockouts in paclitaxel neuropathy and acute and chronic inflammatory pain models, with spinal cord RNA-seq.
- Myeloid-cell α7 nAChR deletion was compared with wild-type controls, and the authors hypothesized this receptor mediates an anti-inflammatory response that limits pain.
- Myeloid-deficient mice showed a marked increase in evoked pain behaviors in CIPN and chronic inflammatory models, with higher pro-inflammatory cytokine gene expression in peripheral sensory tissue; no effect sizes are reported in the abstract.
- The authors conclude that myeloid α7 nAChR signaling is an endogenous cholinergic anti-inflammatory pathway and a potential target for novel analgesics, and enrichment analysis implicated vascular and extracellular matrix pathways.
- Preclinical study in male and female Sprague-Dawley rats using an operant facial pain assay, locomotor monitoring, and conditioned place preference.
- Cannabidiol at 3.2 or 10.0 mg/kg was combined with oxycodone at 0.56 mg/kg, and its effects on analgesia and reward were measured.
- Cannabidiol enhanced oxycodone's antinociceptive effect and did not change oxycodone-induced rearing or conditioned place preference acquisition or expression. The abstract reports no effect sizes or p values.
- The authors conclude that cannabidiol may potentiate oxycodone analgesia without increasing reward-related effects under the conditions tested, supporting study as an opioid-sparing adjunct.
- Population-based observational analysis of 55,721 UK Biobank participants comparing diet quality with acute pain, chronic pain, or pain-free status.
- Five dietary indices (DII, HDI, hPDI, MDS, EAT-Lancet) were modeled against pain status using multinomial logistic regression.
- Higher hPDI (OR 0.993, 95% CI 0.989-0.997), EAT-Lancet (OR 0.969), and MDS (OR 0.981) scores associated with lower chronic pain odds; only hPDI tied to acute pain.
- Subgroup analyses linked hPDI and EAT-Lancet to lower odds of musculoskeletal and localised pain, while lower MDS and higher DII tracked with widespread and non-MSK pain.
- This longitudinal cohort study used plasma and questionnaire data from 116 men and 269 women with traumatic stress exposure, enrolled from emergency departments in the AURORA study.
- The exposure was C-reactive protein measured in the emergency department and again at six months, related to acute and chronic pain severity.
- Peritraumatic CRP did not predict acute pain in either sex, but in men higher peritraumatic CRP predicted lower chronic pain (β=-0.36, p=0.024). In women, six-month CRP was associated with six-month pain (r=0.21, p=0.0015).
- The authors conclude that CRP-pain relationships differ by sex and that inflammation may contribute to different pain recovery trajectories in men and women.
- This diffusion MRI study compared patients with trigeminal neuralgia, scanned before and six months after Gamma Knife radiosurgery, with age- and sex-matched healthy controls from the Cam-CAN dataset.
- The exposure was Gamma Knife radiosurgery, and the comparison was healthy controls, with fornix integrity measured by fractional anisotropy and diffusivity indices.
- Before surgery, patients had lower fornix fractional anisotropy than controls, and this difference persisted six months after radiosurgery.
- Postoperative fornix reductions were greater in male than female patients, and the authors describe a dissociation between clinical pain relief and fornix white matter recovery.
- This preclinical mouse study tested female wild-type and sigma-1 receptor knockout mice in an intracolonic capsaicin model of visceral pain.
- Subcutaneous morphine, oxycodone, or fentanyl were given alone or with sigma-1 receptor antagonists, with naloxone and the agonist PRE-084 used as controls.
- Genetic deletion or antagonist treatment potentiated opioid antinociception, most clearly at sub-antinociceptive doses, and this effect was absent in knockout mice.
- Naloxone reversed both the opioid effect and the potentiation, while PRE-084 did not change opioid efficacy, so the authors propose sigma-1 antagonism as an opioid-sparing adjuvant.
- Test-retest reliability study in 28 healthy volunteers, measuring mechanical pinprick sensitivity at five time points around high-frequency stimulation (HFS) conditioning.
- HFS served as a human model of secondary hyperalgesia, with heterotopic pinprick and homotopic electrically evoked responses assessed, plus CPM, TSP and anxiety as possible influences.
- Secondary hyperalgesia was consistently induced by 50 minutes across sessions, but its development was reduced during session 2; the abstract reports no effect sizes.
- Pain during conditioning, anxiety, CPM and TSP did not predict hyperalgesia development or explain between-session variance; the authors advise counterbalancing and further habituation research.
- Preclinical study that generated a transgenic mouse line whose activated neurons emit bioluminescence, tested across several pain models.
- Spinal bioluminescence was imaged in mice given capsaicin or HIV-1 gp120, or after spinal nerve ligation, as a surrogate for spontaneous pain.
- The authors report the luminescence signal is a sensitive optical surrogate for spontaneous pain, but the abstract gives no effect sizes or statistics.
- They propose the method for basic and translational research and possible automated high-throughput analgesic screening.
- Registry-based study of 1263 patients starting PAD care at 16 vascular centers in the U.S., the Netherlands, and Australia (2011–2015).
- Exposures were PAD severity (resting ABI, Rutherford stage) and depressive symptoms, anxiety, and perceived stress, compared against frequent, intense, sleep-interfering, and chronic pain.
- Psychological factors were linked to frequent, intense, and sleep-interfering pain (ORs 1.58–5.09), with depressive symptoms the strongest correlate, while resting ABI showed no association.
- Over 80% reported heightened pain, and the authors conclude that claudication pain reflects both vascular and psychological dimensions, supporting integrated biopsychosocial assessment.
- Qualitative study using in-depth interviews with 20 patients with advanced cancer and 11 support people about perceived opioid access barriers.
- Participants described barriers at three stages: obtaining prescriptions, obtaining insurance authorization, and filling prescriptions at a pharmacy.
- Barriers were seen as causing avoidable hardship, and participants felt they had few ways to influence opioid policies they viewed as arbitrary.
- The authors call for clearer policy implementation and patient inclusion in policymaking, and for future research with more diverse samples.
- Convergent mixed-methods secondary analysis of survey data from 19 adults with persistent pain who said they did not improve after individual PSE-informed care.
- Participants rated 11 predefined pain concepts on a 6-point Likert scale and gave free-text responses about the concepts most important to them.
- Apart from 'all pain is real' (68% rated very important), most concepts were rated unimportant or unclear, and themes included wanting a clear diagnosis and rejecting the idea that beliefs could change pain.
- The authors suggest limited valuing may reflect disrupted clinician trust and messages that felt implausible or dismissive, and propose strengthening relationships and co-designing clearer messages.
- Preclinical study in male mice with complete Freund's adjuvant-induced chronic inflammatory pain, examining glutamatergic neurons in the pedunculopontine tegmental nucleus and their projections to the central medial thalamus.
- Chemogenetic inhibition of PPTg glutamatergic neurons and of the PPTg-CM pathway was compared with optogenetic activation of these neurons and pathway in naïve mice.
- Chemogenetic inhibition alleviated evoked and spontaneous nociceptive behaviors and anxiety-like behaviors in CFA-treated mice, while optogenetic activation elicited these behaviors in naïve mice; the abstract reports no numerical effect sizes.
- The authors conclude that the PPTg-to-CM glutamatergic projection modulates both nociceptive and anxiety-like behaviors, supporting a shared circuit for pain-anxiety comorbidity.
- Post-hoc secondary analysis of a pilot randomized trial in 42 adults with insomnia and comorbid migraine, mostly female, with a mean age of 43.8 years.
- Insomnia severity, measured by the Insomnia Severity Index (ISI), was modeled as a predictor of migraine disability (MIDAS) and migraine-specific quality of life (MSQv2.1) using linear mixed models.
- Each 1-point rise in ISI was linked to a higher MIDAS rate ratio of 1.10 (95% CI 1.028-1.171, P < .05), and to lower MSQv2.1 scores in restrictive role (B=-1.205, P=.001), preventive role (B=-0.981, P=.020), and emotional function (B=-1.66, P=.001).
- The authors conclude that insomnia severity is significantly associated with migraine disability and quality of life, supporting prevention and sleep intervention in patients with migraine.
- This retrospective-style cohort of 818 young adults with distal lower extremity fracture used in-hospital records and one year of follow-up.
- The authors built a predictive model using LASSO regression, information gain analysis, and multivariable logistic regression, then validated it.
- CPSP developed in 38.4% of patients, and 18.2% of those with CPSP had neuropathic pain; optimism-corrected AUCs were 0.872 development and 0.838 validation.
- Six variables were linked to CPSP, including analgesic technique, fixation type, preoperative management, and early NRS scores, and the authors built a web-based nomogram for discharge use.